132 related articles for article (PubMed ID: 8314235)
21. Parathyroid hormone related protein and skeletal morbidity in breast cancer.
Bundred NJ; Walker RA; Ratcliffe WA; Warwick J; Morrison JM; Ratcliffe JG
Eur J Cancer; 1992; 28(2-3):690-2. PubMed ID: 1591095
[TBL] [Abstract][Full Text] [Related]
22. [Diagnostic significance of parathyroid hormone-related protein in tumor patients with hypercalcemia].
Blind E; Raue F; Meinel T; Pecherstorfer M; Räth U; Schmidt-Gayk H; Kohl B; Ziegler R
Dtsch Med Wochenschr; 1993 Mar; 118(10):330-5. PubMed ID: 8453901
[TBL] [Abstract][Full Text] [Related]
23. Circulating levels of midregional parathyroid hormone-related protein in hypercalcaemia of malignancy.
Blind E; Raue F; Götzmann J; Schmidt-Gayk H; Kohl B; Ziegler R
Clin Endocrinol (Oxf); 1992 Sep; 37(3):290-7. PubMed ID: 1424212
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical localization of parathyroid hormone-related protein in parathyroid adenoma and hyperplasia.
Danks JA; Ebeling PR; Hayman JA; Diefenbach-Jagger H; Collier FM; Grill V; Southby J; Moseley JM; Chou ST; Martin TJ
J Pathol; 1990 May; 161(1):27-33. PubMed ID: 2196348
[TBL] [Abstract][Full Text] [Related]
25. Glypican-3 is useful but not superior to Hep Par 1 in differentiating hepatocellular carcinoma from other liver tumours.
Pour AM; Masir N; Rose IM
Malays J Pathol; 2016 Dec; 38(3):229-233. PubMed ID: 28028292
[TBL] [Abstract][Full Text] [Related]
26. Hypercalcaemia in a patient with fatal adenosquamous carcinoma of the colon.
Links M; Ho H; Clingan P; Diamond T
Med J Aust; 1994 Mar; 160(5):286-7. PubMed ID: 8107631
[TBL] [Abstract][Full Text] [Related]
27. Humoral hypercalcaemia in renal carcinoma due to parathyroid hormone related protein.
Sandhu DP; Munson KW; Harrop JS; Hopton MR; Ratcliffe WA
Br J Urol; 1993 Dec; 72(6):848-50. PubMed ID: 8306145
[TBL] [Abstract][Full Text] [Related]
28. High mobility group A1 is expressed in metastatic adenocarcinoma to the liver and intrahepatic cholangiocarcinoma, but not in hepatocellular carcinoma: its potential use in the diagnosis of liver neoplasms.
Abe N; Watanabe T; Izumisato Y; Suzuki Y; Masaki T; Mori T; Sugiyama M; Fusco A; Atomi Y
J Gastroenterol; 2003; 38(12):1144-9. PubMed ID: 14714251
[TBL] [Abstract][Full Text] [Related]
29. Parathyroid hormone-related protein antigen localization distinguishes between mesothelioma and adenocarcinoma of the lung.
Clark SP; Chou ST; Martin TJ; Danks JA
J Pathol; 1995 Jun; 176(2):161-5. PubMed ID: 7636626
[TBL] [Abstract][Full Text] [Related]
30. Topographical immunohistochemical expression of bcl-2 protein in human liver lesions.
Skopelitou A; Hadjiyannakis M; Alexopoulou V; Krikoni O; Kamina S; Agnantis N
Anticancer Res; 1996; 16(2):975-8. PubMed ID: 8687162
[TBL] [Abstract][Full Text] [Related]
31. Granin-A, parathyroid hormone-related protein, and calcitonin gene products in neuroendocrine prostate cancer.
Deftos LJ
Prostate Suppl; 1998; 8():23-31. PubMed ID: 9690660
[TBL] [Abstract][Full Text] [Related]
32. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
[TBL] [Abstract][Full Text] [Related]
33. Is parathyroid hormone-related protein a sensitive serum marker in advanced breast cancer?
Pyke CM; Menezes G; Purdie DM; Johnson S; Cowley D
Aust N Z J Surg; 1997 May; 67(5):256-9. PubMed ID: 9152154
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone-related peptide in plasma of patients with hypercalcemia and malignant lesions.
Kao PC; Klee GG; Taylor RL; Heath H
Mayo Clin Proc; 1990 Nov; 65(11):1399-407. PubMed ID: 1700240
[TBL] [Abstract][Full Text] [Related]
35. Endocrine markers in malignant tumor cells producing parathyroid hormone-related protein.
Zabel M; Dietel M
Exp Clin Endocrinol; 1993; 101(5):297-302. PubMed ID: 8299706
[TBL] [Abstract][Full Text] [Related]
36. Detection of chromogranin A in human gastric adenocarcinomas using a sensitive immunohistochemical technique.
Qvigstad G; Sandvik AK; Brenna E; Aase S; Waldum HL
Histochem J; 2000 Sep; 32(9):551-6. PubMed ID: 11127976
[TBL] [Abstract][Full Text] [Related]
37. Parathyroid hormone and parathyroid hormone-related protein in the investigation of hypercalcaemia in two hospital populations.
Walls J; Ratcliffe WA; Howell A; Bundred NJ
Clin Endocrinol (Oxf); 1994 Oct; 41(4):407-13. PubMed ID: 7955450
[TBL] [Abstract][Full Text] [Related]
38. Cytoplasmic staining of TTF-1 in the differential diagnosis of hepatocellular carcinoma vs cholangiocarcinoma and metastatic carcinoma of the liver.
Lei JY; Bourne PA; diSant'Agnese PA; Huang J
Am J Clin Pathol; 2006 Apr; 125(4):519-25. PubMed ID: 16627262
[TBL] [Abstract][Full Text] [Related]
39. Parathyroid hormone-related protein expression in the human colon: immunohistochemical evaluation.
Malakouti S; Asadi FK; Kukreja SC; Abcarian HA; Cintron JR
Am Surg; 1996 Jul; 62(7):540-4; discussion 544-5. PubMed ID: 8651548
[TBL] [Abstract][Full Text] [Related]
40. Molecular forms of parathyroid hormone-related protein in tumours and biological fluids.
Bowden SJ; Hughes SV; Ratcliffe WA
Clin Endocrinol (Oxf); 1993 Mar; 38(3):287-94. PubMed ID: 8458100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
